{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-036929","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.985202+00:00","generated_at":"2026-05-31T09:39:19.655583+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"SANUWAVE Q2 revenue $7.2M (+53% YoY); guides Q3 growth 65-75%","bullets":["Q2 revenue $7.2M, up 53% YoY; 72 UltraMist systems sold vs 49 in Q2 2023.","GAAP operating income $2.0M; net income $6.6M vs loss $7.3M YoY.","Adjusted EBITDA $1.5M vs $171K YoY; year-to-date $1.4M vs -$1.6M.","Q3 2024 revenue guidance $8-8.5M (65-75% growth); gross margin mid 70s.","Reverse stock split approved, note/warrant exchange fully subscribed to simplify cap structure."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-036929","json":"https://secwatch.observer/filing/0001140361-24-036929.json","markdown":"https://secwatch.observer/filing/0001140361-24-036929.md","text":"https://secwatch.observer/filing/0001140361-24-036929.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124036929/0001140361-24-036929-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124036929/ef20033924_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:39:19.655583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}